Shares of Aurinia Pharmaceuticals Inc. (AUPH) are surging more than 15% in pre-market trade on Friday at $10.59.
Thursday, the company's Board revealed that it has started exploring strategic alternatives including a sale or merger of the company, among others.
JP Morgan is acting as the financial advisor in the process, the company said.
On Thursday, AUPH closed at $9.16, down 0.22%. It has traded in the range of $4.07 - $12.60 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Business News
December 26, 2025 08:42 ET Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.